Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland

氯氮平 医学 队列 恶性肿瘤 精神分裂症(面向对象编程) 内科学 抗精神病药 队列研究 儿科 癌症 癌症登记处 精神科 肿瘤科
作者
Jari Tiihonen,Antti Tanskanen,J Simon Bell,Jessica L Dawson,Vesa Kataja,Heidi Taipale
出处
期刊:The Lancet Psychiatry [Elsevier BV]
卷期号:9 (5): 353-362 被引量:37
标识
DOI:10.1016/s2215-0366(22)00044-x
摘要

Clozapine is the most efficacious treatment for schizophrenia and is associated with lower overall mortality than are other antipsychotic drugs, despite the risk of agranulocytosis. Preliminary reports over the past 10 years suggest a possible risk of haematological malignancies, but the issue has remained unsettled. We aimed to study the risk of haematological malignancies associated with use of clozapine and other antipsychotics.We did a nationwide case-control (and cohort) study of people with schizophrenia, using prospectively gathered data from Finnish national registers. A nested case-control study was constructed by individually matching cases of lymphoid and haematopoietic tissue malignancy with up to ten controls without cancer by age, sex, and time since first schizophrenia diagnosis. For the case-control study, we restricted inclusion criteria to malignancies diagnosed on a histological basis, and excluded individuals outside of the age range 18-85 years, and any patients that had a previous malignancy. Analyses were done using conditional logistic regression adjusting for comorbid conditions.For the case-control study 516 patients with a first-time diagnosis of lymphoid and haematopoietic tissue malignancy during years 2000-17 and diagnosed after their first diagnosis of schizophrenia were identified. 102 patients were excluded due to diagnosis that was without a histological basis, five patients were excluded because of their age, and 34 were excluded for a previous malignancy, resulting in 375 patients being matched to controls. We selected up to ten controls without cancer (3734 in total) for each case from the base cohort of people with schizophrenia. For the cohort study, data for 55 949 people were included for analysis. Cumulative incidence of haematological malignancies during the mean follow-up of 12·3 years (SD 6·5) was 102 (0·7%) cases among 13 712 patients who had used clozapine (corresponding to event rate of 61 cases per 100 000 person-years), and during mean follow-up of 12·9 years (SD 7·2) was 235 (0·5%) malignancies among 44 171 patients having used other antipsychotic medication than clozapine (corresponding to 41 cases per 100 000 person-years). Of the 375 individuals with haematological malignancies (305 lymphomas, 42 leukaemia, 22 myelomas, 6 unspecified) observed from 2000-17, 208 (55%) were males and 167 (45%) were female. Ethnicity data were not available. Compared with non-use of clozapine (most had used other antipsychotics and a few had used no antipsychotics), clozapine use was associated with increased odds of haematological malignancies in a dose-response manner (adjusted odds ratio 3·35, [95% CI 2·22-5·05] for ≥5000 defined daily dose cumulative exposure, p<0·0001). Exposure to other antipsychotic drugs was not associated with increased odds. A complementary analysis showed that the clozapine-related risk increase was specific for haematological malignancies, because no such finding was observed for other malignancies. Over 17 years of follow-up of the base cohort, 37 deaths occurred due to haematological malignancy among patients exposed to clozapine (26 with ongoing use at time of haematological malignancy diagnosis, and 11 in patients who did not use clozapine at the exact time of their cancer diagnosis), whereas only three deaths occurred due to agranulocytosis.Unlike other antipsychotics, long-term clozapine use is associated with increased odds of haematological malignancies. Long-term clozapine use has a higher effect on mortality due to lymphoma and leukaemia than due to agranulocytosis. However, acknowledging that the absolute risk is small compared with the previously observed absolute risk reduction in all-cause mortality is important. Our results suggest that patients and caregivers should be informed about warning signs of haematological malignancies, and mental health clinicians should be vigilant for signs and symptoms of haematological malignancy in patients treated with clozapine.The Finnish Ministry of Social Affairs and Health and Academy of Finland.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S的应助被科研通管家采纳,获得10
刚刚
天天快乐的应助被科研通管家采纳,获得10
刚刚
刚刚
科目三的应助被科研通管家采纳,获得10
刚刚
CodeCraft的应助被zhangerya采纳,获得10
刚刚
大猫发布了新的文献求助20
刚刚
风格的应助被科研通管家采纳,获得20
刚刚
充电宝的应助被科研通管家采纳,获得10
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
CORAL完成签到,获得积分10
1秒前
null的应助被科研通管家采纳,获得10
1秒前
tttt完成签到 ,获得积分10
1秒前
1秒前
风格的应助被科研通管家采纳,获得30
1秒前
上官若男的应助被陈泓宇采纳,获得10
1秒前
SciGPT的应助被qian采纳,获得10
1秒前
Ava的应助被科研通管家采纳,获得10
1秒前
null的应助被科研通管家采纳,获得10
1秒前
2秒前
江奖姜酱发布了新的文献求助10
3秒前
陈cxz完成签到 ,获得积分10
3秒前
3秒前
十二十三完成签到 ,获得积分10
4秒前
ybk666完成签到,获得积分10
4秒前
grh发布了新的文献求助10
4秒前
慕念完成签到,获得积分10
5秒前
爆米花的应助被魔术师采纳,获得10
5秒前
科目三的应助被咕咕day采纳,获得10
6秒前
eve完成签到,获得积分20
7秒前
华仔的应助被初温采纳,获得10
8秒前
8秒前
在水一方的应助被sunidea采纳,获得10
8秒前
9秒前
moon完成签到,获得积分10
9秒前
anian发布了新的文献求助10
9秒前
科研通AI6.2的应助被Zzz采纳,获得10
11秒前
Mu完成签到,获得积分10
11秒前
迷途书童完成签到,获得积分10
12秒前
情怀的应助被阔达莺采纳,获得10
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817